FR940202-2-00144 FR940202-2-00071 562. Arden NH, Patriarca PA, Fasano MB, et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988; 148:865&hyph;868. 563. Arroyo JC, Postic B, Brown A, et al. Influenza A/Philippines/2/82 outbreak in a nursing home: Limitations of influenza vaccination in the elderly. Am J Infect Control 1984; 12:329&hyph;334. 564. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes: Reduction in illness and complications during influenza A (H3N2) epidemic. JAMA 1985; 253:1136&hyph;1139. 565. Saah AJ, Neufeld R, Rodstein M, et al. Influenza vaccine and pneumonia mortality in a nursing home population. Arch Intern Med 1986; 146:2353&hyph;2357. 566. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966; 122:800&hyph;804. 567. Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter DG. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979; 110:1&hyph;6. 568. Knight V. Airborne transmission and pulmonary deposition of respiratory viruses. In: Mulder J, Hers JFP, eds. Influenza. Groningen, Netherlands: Wolters-Noordhoff, 1972:1&hyph;9. 569. Loosli CG, Lemon HM, Robertson OH, et al. Experimental air-borne influenza infection. I. Influence of humidity on survival of virus in air. Proc Soc Exp Biol Med 1943; 53:205&hyph;206. 570. Bean B, Moore BM, Sterner B, et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982; 146:47&hyph;52. 571. Kilbourne ED. Influenza. New York: Plenum Publishing, 1987. 572. Glezen WP, Decker M, Joseph SW, Mercready RG, Jr. Acute respiratory disease associated with influenza epidemics in Houston, 1981&hyph;1983. J Infect Dis 1987; 155:1119&hyph;1126. 573. McQuillin J, Madeley CR, Kendal AP. Monoclonal antibodies for the rapid diagnosis of influenza A and B virus infections by immunofluorescence. Lancet 1985; 2:911&hyph;914. 574. Berg RA, Yolken RH, Rennard SI, et al. New enzyme immunoassay for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet 1980; 1:851&hyph;853. 575. Espy MJ, Smith TF, Harmon MW, et al. Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol 1986; 24:677&hyph;679. 576. Chomel JJ, Pardon D, Thouvenot D, Allard JP, Aynard M. Comparison between three rapid methods for direct diagnosis of influenza and the conventional isolation procedure. Biologicals 1991; 19:287&hyph;292. 577. Bucher DJ, Mikhail A, Popple S, et al. Rapid detection of type A influenza viruses with monoclonal antibodies to the M protein (M1) by enzyme-linked immunosorbent assay and time-resolved fluoroimmunoassay. J Clin Microbiol 1991; 29:2484&hyph;2488. 578. Spada B, Biehler K, Chegas P, Kaye J, Riepenhoff-Talty M. Comparison of rapid immunofluorescence assay to cell culture isolation for the detection of influenza A and B viruses in nasopharyngeal secretions from infants and children. J Virol Methods 1991; 33:305&hyph;310. 579. Barker WH, Mullooly JP. Influenza vaccination of elderly persons: Reduction in pneumonia and influenza hospitalizations and deaths. JAMA 1980; 244:2547&hyph;2549. 580. Foster DA, Tolsma AN, Newson AF, et al. Influenza vaccine effectiveness in preventing hospitalizations for pneumonia in the elderly. Am J Epidemiol 1992; 136:286&hyph;307. 581. Advisory Committee on Immunization Practices. Prevention and Control of Influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993; 42 (RR&hyph;6):1&hyph;14. 582. Patriarca PA, Weber JA, Parker RA, et al. Risk factors for outbreaks of influenza in nursing homes: A case control study. Am J Epidemiol 1986; 124:114&hyph;119. 583. Fox JP, Elveback L, Scott W, Gatewood L, Ackerman E. Herd immunity: basic concept and relevance to public health immunization practices. Am J Epidemiol 1971; 94:171&hyph;189. 584. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR 1992; 41:1&hyph;17. 585. Tominack RL, Hayden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin N Am 1987; 1:459&hyph;478. 586. Hall CB, Dolin R, Gala CL, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics 1987; 80:275&hyph;282. 587. Dolin R, Reichman RC, Madore HP, et al. A controlled trial of amantadine and rimantadine prophylaxis of influenza infection. N Engl J Med 1982; 307:580&hyph;584. 588. Douglas RG. Drug therapy: prophylaxis and treatment of influenza. N Engl J Med 1990; 322:443&hyph;450. 589. Younkin SW, Betts RF, Roth FK, et al. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment. Antimicrob Agents Chemother 1983; 23:577&hyph;82. 590. Van Voris LP, Betts RF, Hayden FG. Successful treatment of naturally occurring influenza A/USSR/77/H1N1. JAMA 1981; 245:1128&hyph;1131. 591. Atkinson WL, Arden NH, Patriarca PA, et al. Amantadine prophylaxis during an institutional outbreak of type A(H1N1) influenza. Arch Intern Med 1986; 146:1751&hyph;1756. 592. O'Donoghue JM, Ray CG, Terry DW, Jr., Beaty HN. Prevention of nosocomial influenza infection with amantadine. Am J Epidemiol 1973; 97:276&hyph;282. 593. Leeming JK. Amantadine hydrochloride and the elderly. Lancet 1969; 1:313&hyph;314. 594. Postma JU, Tilburg WV. Visual hallucinations and delirium during treatment with amantadine (Symmetrel). J Am Geriatr Soc 1975; 23:212&hyph;215. 595. Ing TS, Daugirdas JT, Soung LS, et al. Toxic effects of amantadine in patients with renal failure. Can Med Assoc J 1979; 120:695&hyph;698. 596. Horadom VW, Sharp JG, Smilack JD, et al. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med 1981; 94:454&hyph;458. 597. Drusano GL, Muncie HL, Hoopes JM, et al. Commonly used methods of estimating creatinine clearance are inadequate for elderly debilitated nursing home patients. J Am Geriatr Soc 1988; 36:437&hyph;441. 598. Hayden FG, Sperber SJ, Belshe RB, Clover RD, Hay AJ, Pyke S. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother 1991; 35:1741&hyph;1747. 599. Mast EE, Harmon MW, Gravenstein S, et al. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A(H3N2). Am J Epidemiol 1991; 13:988&hyph;997. 600. Hayden PG, Blake RB, Clover RD, Hey AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321:1696&hyph;1702. 601. Hayden FG, Couch RB. Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimantadine. Rev Med Virol 1992; 2:89&hyph;96. 602. Monto AS, Arden NH. Implications of viral resistance to amantadine in control of influenza A. Clin Infect Dis 1992; 15:362&hyph;367. 603. Fedson DS. Immunizations for health care workers and patients in hospitals. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infection. Baltimore: Williams and Wilkins, 1987:116&hyph;174. 604. Valenti WM, Betts RF, Hall CB, Hruska JF, Douglas RG, Jr. Nosocomial viral infections: II. Guidelines for prevention and control of respiratory viruses, herpesviruses, and hepatitis viruses. Infect Control 1981; 1:165&hyph;178. 605. Williams WW. Guideline for infection control in hospital personnel. Infect Control 1983; 4:326&hyph;349.
